Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Outcome Prediction
100%
Expression Level
100%
Stage I Lung Cancer
100%
MicroRNA Expression
100%
MiR-221
100%
Tumor
75%
MicroRNA
50%
Recurrent Disease
50%
CDKN1C
50%
Lung
25%
High Risk
25%
MicroRNA-21 (miR-21)
25%
After Surgery
25%
Tumor Recurrence
25%
Risk for Relapse
25%
Surgical Resection
25%
Invasiveness
25%
Clinical Predictors
25%
Tumor Tissue
25%
Recurring
25%
Human Malignancies
25%
Same Patient
25%
Curative Resection
25%
MicroRNA-155 (miR-155)
25%
Patients at Risk
25%
Formalin-fixed Paraffin-embedded Tissue
25%
Healthy Lung
25%
Relapse Risk
25%
Chemokine Ligand 12 (CXCL12)
25%
MiRNA Expression
25%
Resectable Lung Cancer
25%
Relapse Predictors
25%
Molecular Predictors
25%
Cancer Phenotype
25%
Downstream Target Genes
25%
Triplicate
25%
CDKN1B
25%
Non-recurrence
25%
Parallel Measurements
25%
MiR-7
25%
MicroRNA-7
25%
MiR-210
25%
Medicine and Dentistry
microRNA
100%
Non Small Cell Lung Cancer
100%
Neoplasm
66%
microRNA 221
66%
Surgery
33%
Recurrent Disease
33%
Lung
33%
Malignant Neoplasm
16%
Cancer
16%
Prospective Study
16%
Downregulation
16%
Tumor Recurrence
16%
Formaldehyde
16%
CDKN1B
16%
microRNA 155
16%
microRNA 210
16%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
microRNA
100%
Neoplasm
66%
microRNA 221
66%
Recurrent Disease
33%
Malignant Neoplasm
16%
Prospective Study
16%
Tumor Recurrence
16%
Formaldehyde
16%
microRNA 155
16%
Cyclin Dependent Kinase Inhibitor 1B
16%
microRNA 210
16%
Neuroscience
MicroRNA
100%
microRNA 221
80%
MiR-155
20%
Cyclin Dependent Kinase Inhibitor 1B
20%
microRNA 210
20%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Downregulation
20%
Prospective Study
20%
CDKN1B
20%
MiR-155
20%
Immunology and Microbiology